Join to View Full Profile
250 25th Ave NSuite 100Nashville, TN 37203
Phone+1 919-668-1748
Dr. Hamilton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2013
University of North Carolina HospitalsResidency, Internal Medicine, 2007 - 2009
University of North Carolina at Chapel Hill School of MedicineClass of 2007
Certifications & Licensure
TN State Medical License 2013 - 2027
NC State Medical License 2007 - 2014
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2- early breast cancer.Erika P Hamilton, Sibylle Loibl, Thomas Bachelot, Michael Gnant, Naoki Niikura
Future Oncology. 2025-03-01 - 9 citationsDatopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Brea...Aditya Bardia, Komal Jhaveri, Seock-Ah Im, Sonia Pernas, Michelino De Laurentiis
Journal of Clinical Oncology. 2025-01-20 - First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.Nehal J Lakhani, Daphne Stewart, Debra L Richardson, Lauren E Dockery, Linda Van Le
Journal for Immunotherapy of Cancer. 2025-01-11
Press Mentions
Pathway Optimization in Early Breast Cancer: Biomarkers, Therapies, and Shared Decision-MakingFebruary 7th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
